MolecularMD, Memorial Sloan-Kettering Cancer Center, New York University deal

The university and the center granted MolecularMD an exclusive, U.S. license to U.S. Patent No. 7,442,507 B2, which covers methods to detect the BRAF V600E mutation through the use of a fluorescent-b...